FDA, Industry Push to Tweak Accelerated Approval Pathway Likely to Have …
FDA, industry push to tweak accelerated approval pathway likely to have …
Filed under: Seattle Drug Treatment Centers
A US Food and Drug Administration (FDA) plan to hasten approvals and improve FDA-industry coordination will likely have minor impact on mid-to-large pharma, four drug industry consultants told BioPharm Insight. FDA is … who moderated the panel: use …
Read more on Financial Times
Lenalidomide Holds Promise in Mantle Cell Lymphoma
Filed under: Seattle Drug Treatment Centers
ATLANTA, Georgia — Lenalidomide ( Revlimid), an immunomodulatory agent approved for use in multiple myeloma, has shown promise in the treatment of mantle cell lymphoma (MCL), one of the rarest non-Hodgkin's lymphomas. In a very large phase 2 trial …
Read more on Medscape
Recovering addicts hand out gifts to the needy
Filed under: Seattle Drug Treatment Centers
Therapists have told officials homeless residents at Mariners Inn, a substance abuse treatment center for men, are jumping at the chance to take part in its Adopt-A-Family program, the Detroit Free Press reported (http://on.freep.com/VcsXHl ) Saturday.
Read more on Seattle Post Intelligencer
Oncothyreon's phase III trial of L-BLP25 to treat NSCLC fails to meet primary …
Filed under: Seattle Drug Treatment Centers
… immunotherapies in the treatment of this devastating disease and we intend to discuss these data with scientific community and regulatory authorities to gain their advice on potential next steps," said Dr. Annalisa Jenkins, Head of Global Drug …
Read more on pharmabiz.com